225 related articles for article (PubMed ID: 9682703)
1. The effects of topical nonsteroidal anti-inflammatory drugs on adenoviral replication.
Gordon YJ; Araullo-Cruz T; Romanowski EG
Arch Ophthalmol; 1998 Jul; 116(7):900-5. PubMed ID: 9682703
[TBL] [Abstract][Full Text] [Related]
2. Effects of diclofenac or ketorolac on the inhibitory activity of cidofovir in the Ad5/NZW rabbit model.
Romanowski EG; Gordon YJ
Invest Ophthalmol Vis Sci; 2001 Jan; 42(1):158-62. PubMed ID: 11133861
[TBL] [Abstract][Full Text] [Related]
3. Effects of topical ketorolac and diclofenac on normal corneal sensation.
Sun R; Gimbel HV
J Refract Surg; 1997; 13(2):158-61. PubMed ID: 9109072
[TBL] [Abstract][Full Text] [Related]
4. Topical corticosteroids reverse the antiviral effect of topical cidofovir in the Ad5-inoculated New Zealand rabbit ocular model.
Romanowski EG; Araullo-Cruz T; Gordon YJ
Invest Ophthalmol Vis Sci; 1997 Jan; 38(1):253-7. PubMed ID: 9019458
[TBL] [Abstract][Full Text] [Related]
5. The effects of corticosteroids of adenoviral replication.
Romanowski EG; Roba LA; Wiley L; Araullo-Cruz T; Gordon YJ
Arch Ophthalmol; 1996 May; 114(5):581-5. PubMed ID: 8619769
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of topical cidofovir on multiple adenoviral serotypes in the New Zealand rabbit ocular model.
Romanowski EG; Gordon YJ
Invest Ophthalmol Vis Sci; 2000 Feb; 41(2):460-3. PubMed ID: 10670476
[TBL] [Abstract][Full Text] [Related]
7. Topical HPMPC inhibits adenovirus type 5 in the New Zealand rabbit ocular replication model.
Gordon YJ; Romanowski EG; Araullo-Cruz T
Invest Ophthalmol Vis Sci; 1994 Nov; 35(12):4135-43. PubMed ID: 7960596
[TBL] [Abstract][Full Text] [Related]
8. Topical corticosteroids of limited potency promote adenovirus replication in the Ad5/NZW rabbit ocular model.
Romanowski EG; Yates KA; Gordon YJ
Cornea; 2002 Apr; 21(3):289-91. PubMed ID: 11917178
[TBL] [Abstract][Full Text] [Related]
9. Comparison of ketorolac tromethamine, diclofenac sodium, and moist drops for ocular pain after radial keratotomy.
McDonald MB; Brint SF; Caplan DI; Bourque LB; Shoaf K
J Cataract Refract Surg; 1999 Aug; 25(8):1097-108. PubMed ID: 10445196
[TBL] [Abstract][Full Text] [Related]
10. A randomized double-masked trial comparing ketorolac tromethamine 0.5%, diclofenac sodium 0.1%, and prednisolone acetate 1% in reducing post-phacoemulsification flare and cells.
el-Harazi SM; Ruiz RS; Feldman RM; Villanueva G; Chuang AZ
Ophthalmic Surg Lasers; 1998 Jul; 29(7):539-44. PubMed ID: 9674003
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of topical immunoglobulins against experimental adenoviral ocular infection.
Nwanegbo EC; Romanowski EG; Gordon YJ; Gambotto A
Invest Ophthalmol Vis Sci; 2007 Sep; 48(9):4171-6. PubMed ID: 17724203
[TBL] [Abstract][Full Text] [Related]
12. Effect of ketorolac on Pseudomonas aeruginosa ocular infection in rabbits.
Fraser-Smith EB; Matthews TR
J Ocul Pharmacol; 1988; 4(2):101-9. PubMed ID: 3262701
[TBL] [Abstract][Full Text] [Related]
13. Comparative effects of ketorolac 0.5% or diclofenac 0.1% ophthalmic solutions on inflammation after cataract surgery.
Flach AJ; Dolan BJ; Donahue ME; Faktorovich EG; Gonzalez GA
Ophthalmology; 1998 Sep; 105(9):1775-9. PubMed ID: 9754191
[TBL] [Abstract][Full Text] [Related]
14. Effect of diclofenac, ketorolac, and fluorometholone on arachidonic acid metabolites following excimer laser corneal surgery.
Phillips AF; Hayashi S; Seitz B; Wee WR; McDonnell PJ
Arch Ophthalmol; 1996 Dec; 114(12):1495-8. PubMed ID: 8953982
[TBL] [Abstract][Full Text] [Related]
15. Corneal sensitivity and burning sensation. Comparing topical ketorolac and diclofenac.
Seitz B; Sorken K; LaBree LD; Garbus JJ; McDonnell PJ
Arch Ophthalmol; 1996 Aug; 114(8):921-4. PubMed ID: 8694724
[TBL] [Abstract][Full Text] [Related]
16. Multiple adenoviral serotypes demonstrate host range extension in the New Zealand rabbit ocular model.
Romanowski EG; Araullo-Cruz T; Gordon YJ
Invest Ophthalmol Vis Sci; 1998 Mar; 39(3):532-6. PubMed ID: 9501863
[TBL] [Abstract][Full Text] [Related]
17. N-chlorotaurine is an effective antiviral agent against adenovirus in vitro and in the Ad5/NZW rabbit ocular model.
Romanowski EG; Yates KA; Teuchner B; Nagl M; Irschick EU; Gordon YJ
Invest Ophthalmol Vis Sci; 2006 May; 47(5):2021-6. PubMed ID: 16639011
[TBL] [Abstract][Full Text] [Related]
18. Topical cyclosporine A inhibits subepithelial immune infiltrates but also promotes viral shedding in experimental adenovirus models.
Romanowski EG; Pless P; Yates KA; Gordon YJ
Cornea; 2005 Jan; 24(1):86-91. PubMed ID: 15604872
[TBL] [Abstract][Full Text] [Related]
19. Effect of topical diclofenac and ketorolac on patient discomfort and corneal sensitivity.
Narváez J; Kroll P; Guzek JP
J Refract Surg; 2002; 18(2):145-8. PubMed ID: 11934203
[TBL] [Abstract][Full Text] [Related]
20. Ketorolac tromethamine 0.5% ophthalmic solution in the treatment of moderate to severe ocular inflammation after cataract surgery: a randomized, vehicle-controlled clinical trial.
Heier J; Cheetham JK; Degryse R; Dirks MS; Caldwell DR; Silverstone DE; Rosenthal A
Am J Ophthalmol; 1999 Mar; 127(3):253-9. PubMed ID: 10088733
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
